normal diastolic blood pressure which is found primarily in elderly people as caused by stiffening of the aorta artery that increases as the person ages (Arcangelo, Peterson, Reinhold, & Wilbur, 2017, p. 257). As people get older, risks for acquiring diseases are higher and deciding an appropriate treatment plan needs to consider the patient’s age, and their underlying medical conditions as some drugs can negatively affect the presence of other diseases. As illustrated in the scenario of HM, his medical history contains multiple health conditions such as hypertension,hyperlipidemia, diabetes, ischemic heart disease, atrial fibrillation and a transient ischemic attack. The presence of age and complicated medical conditions requires careful consideration in the development of a treatment plan as age differences can affect drug absorption and combining multiple medications can interfere with the effectivity of other drug actions.
Age Influence on the Pharmacokinetic and Pharmacodynamics ProcessesAging is known to be associated with an increased prevalence of multiple chronic diseases and use of sophisticated therapeutic regimens; therefore, increased attention is needed due to age-related changes in pharmacokinetics and pharmacodynamics including their co-morbidity and polypharmacy (Bondesson et al., 2013). Improving the drug therapy for the elderly population can be challenging due to their physiological changes and the presence of multiple illnesses. Besides the presence of comorbidities, age alone can affect how drugs and body interact. Age-related changes include changes in metabolism and body composition which affects how medications are distributed to different parts of the body (Health in Aging, 2015). When developing a plan of care for the elderly, review of medical history including their current medications must be evaluated before recommending additional treatment regimens. Drug Therapy PlanThe presence of hypertension, hyperlipidemia, diabetes, and ischemic heart disease with the history of atrial fibrillation and transient ischemic attack (TIA) increases the risks of HM for acquiring cardiovascular conditions which can lead to sudden heart attack or stroke. The goal of HM’s drug therapy is to control his cardiovascular uncertainties at the same time, avoid unnecessary medications that can increase the possibility of developing adverse side effects. As ahigh risk of stroke due to clot formation caused by atrial fibrillation and history of TIA, HM was prescribed with anticoagulation drugs such as Aspirin and Warfarin. The use of multiple blood
You've reached the end of your free preview.
Want to read all 7 pages?
- Fall '13
- Nurs 6521 Marcus, Et Al., 2014).